APA (7th ed.) Citation

M, L., D, W., AS, V., JS, S., OE, R., FS, H., . . . S, G. (2022). Effect of corticosteroid dosing on outcomes in high-grade immune checkpoint inhibitor hepatitis. Hepatology (Baltimore, Md.), 75(3), 531. https://doi.org/10.1002/hep.32215

Chicago Style (17th ed.) Citation

M, Li, Wong D, Vogel AS, Sack JS, Rahma OE, Hodi FS, Zucker SD, and Grover S. "Effect of Corticosteroid Dosing on Outcomes in High-grade Immune Checkpoint Inhibitor Hepatitis." Hepatology (Baltimore, Md.) 75, no. 3 (2022): 531. https://doi.org/10.1002/hep.32215.

MLA (9th ed.) Citation

M, Li, et al. "Effect of Corticosteroid Dosing on Outcomes in High-grade Immune Checkpoint Inhibitor Hepatitis." Hepatology (Baltimore, Md.), vol. 75, no. 3, 2022, p. 531, https://doi.org/10.1002/hep.32215.